期刊文献+

充血性心力衰竭患者甲状腺激素异常变化及其临床意义 被引量:6

Change of thyroid hormone and its clinic signincance in congestive heart failure
在线阅读 下载PDF
导出
摘要 目的探讨充血性心力衰竭(CHF)患者甲状腺激素异常变化及临床意义。方法采用放射免疫法检测30例正常对照组及45例CHF患者,血浆三碘甲状腺原氨酸(T3)、四碘甲状腺原氨酸(T4)、反三碘甲状腺原氨酸(rT3)及促甲状腺激素(TSH)的浓度。结果CHF组T3、T4明显低于对照组,而rT3明显高于对照组,心力衰竭越重,降低越明显,不同程度CHF患者,组间T3、rT3差异显著,二者均有统计学意义,两组之间的TSH无统计学意义。结论提示T3、rT3的变化可作为反映心力衰竭患者心功能状态的指标之一。 Objective To determine the prevalence and clinic significance of abnormal thyroid hormone metabolism in congestive heart failure(CHF). Methods 30 controls and 45 CHF patients were divided into three groups according to the degree of heart failure. Free triiodothyronine ( T3 ) index, free thyroxine ( T4 ) index, reverse T3 and thyrotropin levels were analyzed by radioimmunoassay. Results In CHF patients the level of serum T3, T4 were lower than control group. The level of rT3 increased markedly in CHF patients. In severe patients with severe CHF, the change of T3 and rT3, was bigger than the mild patients. There was a great change among different degree of CHF. The level of serum TSH between CHF patients and controls was no statistical significance. Conclusion T3. rT3 levels could be taken as determinative indicators which reflect severity of CHF.
作者 任骞 刘玉杰
出处 《中国心血管杂志》 2006年第3期189-190,共2页 Chinese Journal of Cardiovascular Medicine
关键词 充血性心力衰竭 甲状腺激素 Congestive heart failure Thyroid hormone
  • 相关文献

参考文献5

二级参考文献29

  • 1张贵生,陈光辉,李隆贵.充血性心力衰竭时甲状腺激素异常变化的研究进展[J].国外医学(心血管疾病分册),1996,23(5):259-262. 被引量:53
  • 2张玉顺 李寰(等).甲状腺激素治疗心血管疾病的研究进展[J].心血管病学进展,1998,19(5):28-28.
  • 3[13]Ririe DG,Butterworth JF,Royster RL,et al.Triiodothyronine increases contractility independent of beta-adrenergic receptors of stimulation of cyclic-3′,5′-adenosine monophosphate.Anesthesiology,1995,82(4):1 004-1 012.
  • 4[14]Moruzzi P,Doria E,Agostini PG,et al.Usefulness of I-thyroxine to imrove cardiac and exercise performance in idiopathic dilated cardiomyopathy.Am J Cardiol,1994,73:374.
  • 5[15]Fruhwald FM,Folikar R,Rurger AG,et al.The thyroid and the heart.Circulation,1993,87:1 435.
  • 6[16]Hamilton MA,Stevenson LW,Fonarow GC,et al.Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure.Am J Cardiol,1998,81(4):443-447.
  • 7[17]Morkin E,Pennock GD,Raya TE,et al.Development of a thyroid hormone analogue for the treatment of congestive heart failure.Thyroid,1996,6(5):521-526.
  • 8[18]Wickenden AD,Kaprielian R,You XM,et al.The thyroid hormone analog DITPA restores I(to) in rats after myocardial infraction.Am J Physiol heart Circ Physiol,2000,278(4):H1 105-1 116.
  • 9[19]Klemperer JD,Ojamaa K,Klein I.thyroid hormone therapy in cardiovascular disease.Prog Cardiovasc Dis,1996,38(4):329-336.
  • 10[2]Hamilton MA.Pplevelence and clinical implications of abnormal thyroid hormore melabolism in advanced heart failure.Ann Thorac Surg,1993,56(Suppl):48.

共引文献30

同被引文献44

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部